SURGIFLO
Clinical Indication
Surgical sites as an adjunct to hemostasis when control of bleeding by ligature or conventional methods is ineffective is impractical
Date of classification
November 2022
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.